VTVT: Utang jangka cendhak perusahaan vTv Therapeutics, Inc.

vTv Therapeutics Inc. develops unique drugs to combat Alzheimer's disease and diabetes by activating cellular defense. A team of top-tier biochemists operates in an agile environment, incentivized by RSU programs. The company's environmental profile is limited to compliance with laboratory disposal regulations. The short-term debt trend reflects liquidity dynamics, where 0.00 represents the latest metric reading.

Short-term debt measures the volume of obligations with a maturity of up to one year, allowing an investor to assess liquidity and the issuer's dependence on external funding. By analyzing the history of short-term liabilities on GURU.Markets, one can filter out market noise and determine whether vTv Therapeutics Inc. (VTVT) has sufficient resources to fund clinical trials of oral drugs before receiving royalties and insurance payments.